SCHEMBL14510734

SCHEMBL14510734

Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3O)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 15/20 0.81
▸ KDM4E B2RXH2 5/20 0.81
▸ HSD17B10 Q99714 4/20 0.81
▸ MAPT P10636 3/20 0.81
▸ PMP22 Q01453 3/20 0.81
▸ TSHR P16473 3/20 0.81
▸ THPO P40225 3/20 0.81
▸ ADRA2A P08913 2/20 0.81
▸ CYP2D6 P10635 2/20 0.81
▸ MTOR P42345 2/20 0.81
▸ MEN1 O00255 1/20 0.81
▸ CYP1A2 P05177 1/20 0.81
▸ CYP3A4 P08684 1/20 0.81
▸ KMT2A Q03164 1/20 0.81
▸ DRD2 P14416 8/20 0.78
▸ HTR2A P28223 5/20 0.78
▸ ALOX15 P16050 2/20 0.65
▸ HIF1A Q16665 2/20 0.65
▸ NFKB1 P19838 1/20 0.65
▸ MAPK1 P28482 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30231809 0.90 DRD1 (1.00) DRD1KDM4EHSD17B10MAPTPMP22
SCHEMBL30026797 0.90 DRD1 (1.00) DRD1KDM4EHSD17B10MAPTPMP22
SCHEMBL2970804 0.90 DRD1 (1.00) DRD1KDM4EHSD17B10MAPTPMP22
Bromide SCHEMBL12610614 0.89 DRD1 (1.00) DRD1KDM4EHSD17B10MAPTPMP22
Bromide SCHEMBL29634914 0.89 DRD1 (1.00) DRD1KDM4EHSD17B10MAPTPMP22
SCHEMBL14495015 0.87 DRD1 (0.79) DRD1KDM4EHSD17B10MAPTPMP22
SCHEMBL14495044 0.87 DRD1 (0.72) DRD1KDM4EHSD17B10MAPTPMP22
SCHEMBL14495025 0.86 DRD1 (0.70) DRD1KDM4EHSD17B10MAPTPMP22
SCHEMBL11256942 0.80 DRD1 (0.76) DRD1KDM4EHSD17B10MAPTPMP22
Hydrochloric Acid SCHEMBL11165963 0.79 DRD1 (0.74) DRD1KDM4EHSD17B10MAPTPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142399-A1 Dual function drugs and uses thereof PSYCHIATRIC GENOMICS, INC. (US) 2007-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142399-A1 Dual function drugs and uses thereof COMT, DRD2, SLC6A3 DRD1 6/4885KDM4E 3362/4885HSD17B10 624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback